(Q37970311)

26 August 2017

Autoantibody-negative autoimmune hepatitis (English)

1 reference

26 August 2017

1 reference

Albert J Czaja

1

1 reference

26 August 2017

21 December 2011

1 reference

Digestive Diseases and Sciences

26 August 2017

1 reference

26 August 2017

57

1 reference

26 August 2017

3

1 reference

26 August 2017

610-624

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-011-2017-z

26 August 2017

0 references

cites work

Diagnosis and management of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Autoimmune hepatitis. Part B: diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Rapidity of treatment response and outcome in type 1 autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Performance parameters of the diagnostic scoring systems for autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Cryptogenic chronic hepatitis and its changing guise in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Diagnostic value of anti-F-actin antibodies in a French multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Steroid treatment for severe acute cryptogenic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Favorable outcomes of autoimmune hepatitis in a community clinic setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Autoimmune fulminant liver failure in adults: Experience in a Japanese center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Etiology and outcome of acute liver failure: retrospective analysis of 50 patients treated at a single center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Immune phenotype of chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Update on hereditary hemochromatosis and the HFE gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Liver abnormalities in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Optimizing diagnosis from the medical liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Simplified criteria for the diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Current and future treatments of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Immunosuppressive drugs: the first 50 years and a glance forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Epidemiology and individual susceptibility to adverse drug reactions affecting the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Liver transplantation for autoimmune hepatitis: fulminant versus chronic hepatitis presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Long-term outcome of liver transplantation for autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Liver transplantation for autoimmune hepatitis: a single-center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Transplantation for autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Keratin 8 mutations in patients with cryptogenic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Natural history of unexplained chronic hepatitis after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Pathogenesis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Autoimmune hepatitis. Part A: pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Aetiopathogenesis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Autoantibodies as prognostic markers in autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Human asialoglycoprotein receptor as an autoantigen in chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Asialoglycoprotein receptor facilitates hemolysis in patients with alcoholic liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Detection of circulating autoantibodies directed against the asialoglycoprotein receptor using recombinant receptor subunit H1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Autoantibodies in the Diagnosis and Management of Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

"Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Anti-actin antibodies: a new test for an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

An actin-myosin functional assay for analysis of smooth muscle (anti-microfilament) autoantibodies in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Smooth muscle autoantibodies with F-actin specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Detection of a Liver-Membrane Autoantibody in HBsAg-negative Chronic Active Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Frequency and significance of antibodies to histones in autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Frequency and significance of antibodies to chromatin in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

DNA vaccination breaks tolerance for a neo-self antigen in liver: a transgenic murine model of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Understanding the pathogenesis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Aetiopathogenesis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

CD4+CD25+ T regulatory cells and TGF-beta in mucosal immune system: the good and the bad.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Molecular mimicry and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Drug-induced autoimmune-like hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Coeliac disease hidden by cryptogenic hypertransaminasaemia

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

21 January 2018

12 December 2020

Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-2017-Z

Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis

21 January 2018

1 reference

12 December 2020

Cryptogenic or autoimmune hepatitis

1 reference

12 December 2020

Liver transplantation for cryptogenic cirrhosis

1 reference

12 December 2020

Smooth muscle autoantibodies and autoantigens

1 reference

12 December 2020

Molecular mimicry and immune-mediated diseases

1 reference

12 December 2020

Study of antigenic sites on the asialoglycoprotein receptor recognized by autoantibodies

1 reference

12 December 2020

Performance parameters of the conventional serological markers for autoimmune hepatitis

1 reference

12 December 2020

Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation

1 reference

12 December 2020

Behavior and significance of autoantibodies in type 1 autoimmune hepatitis

1 reference

12 December 2020

Fine specificity and subclasses of IgG anti-actin autoantibodies differ in health and disease

1 reference

12 December 2020

Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro

1 reference

12 December 2020

Validation of scoring system for diagnosis of autoimmune hepatitis

1 reference

12 December 2020

Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH

1 reference

12 December 2020

Improved diagnoses of autoimmune hepatitis using an anti-actin ELISA

1 reference

12 December 2020

Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease

1 reference

12 December 2020

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

12 December 2020

Failure of autoimmune antibody to react with antigen prepared from the individual's own tissues

1 reference

12 December 2020

Nonstandard antibodies as prognostic markers in autoimmune hepatitis

1 reference

12 December 2020

Is ANCA really related to chronic liver disease?

1 reference

12 December 2020

Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis

1 reference

12 December 2020

Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis

1 reference

12 December 2020

Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis

1 reference

12 December 2020

Autoantibodies in autoimmune liver disease

1 reference

12 December 2020

NASH and cryptogenic cirrhosis: a histological analysis.

1 reference

12 December 2020

Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis

1 reference

12 December 2020

Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies

1 reference

12 December 2020

Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis

1 reference

12 December 2020

The nature and prognosis of severe cryptogenic chronic active hepatitis.

1 reference

12 December 2020

Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypes.

1 reference

12 December 2020

Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

1 reference

12 December 2020

Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis

1 reference

12 December 2020

Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease

1 reference

12 December 2020

Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2

1 reference

12 December 2020

Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1

1 reference

12 December 2020

Current status of autoimmune hepatitis in Japan

1 reference

12 December 2020

Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis

1 reference

12 December 2020

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

1 reference

12 December 2020

Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis

1 reference

12 December 2020

Anti-tRNP(ser)sec/SLA/LP autoantibodies. Comparative study using in-house ELISA with a recombinant 48.8 kDa protein, immunoblot, and analysis of immunoprecipitated RNAs

1 reference

12 December 2020

Thermolabile and calcium-dependent serum factor interferes with polymerized actin, and impairs anti-actin antibody detection

1 reference

12 December 2020

Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis

1 reference

12 December 2020

Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis

1 reference

12 December 2020

Clinicopathological features of acute-onset autoimmune hepatitis

1 reference

12 December 2020

Features and consequences of untreated type 1 autoimmune hepatitis

1 reference

12 December 2020

Primary liver transplantation for autoimmune hepatitis: A comparative analysis of the European Liver Transplant Registry

1 reference

12 December 2020

Anti-asialoglycoprotein receptor autoantibodies, detected by a capture-immunoassay, are associated with autoimmune liver diseases

1 reference

12 December 2020

Genetic distinctions between types 1 and 2 autoimmune hepatitis

1 reference

12 December 2020

Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis

1 reference

12 December 2020

LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity

1 reference

12 December 2020

Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview

1 reference

12 December 2020

Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis

1 reference

12 December 2020

Liver dysfunction in celiac disease.

1 reference

12 December 2020

Nature and behavior of serum cytokines in type 1 autoimmune hepatitis

1 reference

12 December 2020

Acute-onset autoimmune hepatitis resembling acute hepatitis: a case report and review of reported cases.

1 reference

12 December 2020

Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse

1 reference

12 December 2020

Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis

1 reference

12 December 2020

Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: a longitudinal study

1 reference

12 December 2020

Anti-neutrophil antibodies in chronic viral hepatitis

1 reference

12 December 2020

Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients.

1 reference

12 December 2020

Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis

1 reference

12 December 2020

Prevalence of IgG autoantibody against F-actin in patients suspected of having autoimmune or acute viral hepatitis

1 reference

12 December 2020

Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis

1 reference

12 December 2020

Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria

1 reference

12 December 2020

Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with autoimmune hepatitis

1 reference

12 December 2020

Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis

1 reference

12 December 2020

Cytokine profile of viral and autoimmune chronic active hepatitis

1 reference

12 December 2020

Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis

1 reference

12 December 2020

Frequency and significance of phenotypes for alpha1-antitrypsin deficiency in type 1 autoimmune hepatitis

1 reference

12 December 2020

An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis

1 reference

12 December 2020

Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis

1 reference

12 December 2020

Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus

1 reference

12 December 2020

Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease

1 reference

12 December 2020

Clinical significance of autoantibody to hepatocyte membrane antigen in type 1 autoimmune hepatitis

1 reference

12 December 2020

Pathogenesis of autoimmune hepatitis

1 reference

12 December 2020

Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis

1 reference

12 December 2020

The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study

1 reference

12 December 2020

Frequency and significance of antibodies to chromatin in autoimmune hepatitis type I

1 reference

12 December 2020

Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group

1 reference

12 December 2020

Evolving concepts in the diagnosis, pathogenesis and treatment of autoimmune hepatitis

1 reference

12 December 2020

The role of autoantibodies as diagnostic markers of autoimmune hepatitis

1 reference

12 December 2020

Serum levels of cytokines in chronic liver diseases

1 reference

12 December 2020

Animal models of autoimmune hepatitis

1 reference

12 December 2020

Antilactoferrin antibodies in autoimmune liver diseases.

1 reference

12 December 2020

Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

1 reference

12 December 2020

Anti-alpha-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis

1 reference

12 December 2020

Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis

1 reference

12 December 2020

Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders

1 reference

12 December 2020

Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis

1 reference

12 December 2020

10.1007/S10620-011-2017-Z

Identifiers

DOI

1 reference

release_4kc27rt7wbfmfohwa2dxkqfjj4

26 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4kc27rt7wbfmfohwa2dxkqfjj4

24 November 2022

mapped directly with Wikidata item

PubMed ID

22187100

1 reference

PubMed ID

22187100